Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase (vol 8, pg 1808, 2018)
THERANOSTICS（2021）
摘要
[This corrects the article DOI: 10.7150/thno.23177.].
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要